X0508 4 2025-05-23 0001034842 RIGEL PHARMACEUTICALS INC RIGL 0001654337 Ali-Jackson Kamil C/O RIGEL PHARMACEUTICALS, INC. 611 GATEWAY BLVD, SUITE 900 SOUTH SAN FRANCISCO CA 94080 true false Common Stock 2025-05-23 4 A 0 2500 0 A 9375 D Stock Option (Right to Buy) 18.95 2025-05-23 4 A 0 3000 0 A 2035-05-23 Common Stock 3000 3000 D The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors. This number has been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024. The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors. /s/ Raymond Furey (Attorney-in-Fact) 2025-05-28